GR1002471B - Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν. - Google Patents

Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν.

Info

Publication number: GR1002471B
Authority: GR; Greece
Prior art keywords: preparation; piperazinecarboxylic acid; pharmaceutical compositions; compositions containing; disorders
Prior art date: 1987-02-18

Application number

GR880100084A

Other languages

Greek (el)

English (en)

Other versions

GR880100084A (el

Inventor

Bernhard Dr. Aebischer

Original Assignee

Novartis Ag (Novartis Sa) (Novartis Inc.)

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-02-18

Filing date

1988-02-16

Publication date

1996-11-15

1988-02-16 Application filed by Novartis Ag (Novartis Sa) (Novartis Inc.) filed Critical Novartis Ag (Novartis Sa) (Novartis Inc.)

1988-12-16 Publication of GR880100084A publication Critical patent/GR880100084A/el

1996-11-15 Publication of GR1002471B publication Critical patent/GR1002471B/el

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GR880100084A 1987-02-18 1988-02-16 Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν. GR1002471B (el)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB878703749A GB8703749D0 (en)	1987-02-18	1987-02-18	Piperazinecarboxylic acid

Publications (2)

Publication Number	Publication Date
GR880100084A GR880100084A (el)	1988-12-16
GR1002471B true GR1002471B (el)	1996-11-15

Family

ID=10612501

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR880100084A GR1002471B (el)	1987-02-18	1988-02-16	Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν.

Country Status (28)

Country	Link
JP (1)	JPH0723387B2 (xx)
KR (1)	KR960015190B1 (xx)
AT (1)	AT391320B (xx)
AU (1)	AU613009B2 (xx)
BE (1)	BE1002427A3 (xx)
CA (1)	CA1327799C (xx)
CH (1)	CH675125A5 (xx)
CY (1)	CY1739A (xx)
DE (1)	DE3804936C2 (xx)
DK (1)	DK168441B1 (xx)
ES (2)	ES2011319A6 (xx)
FI (1)	FI86733C (xx)
FR (1)	FR2610932B1 (xx)
GB (2)	GB8703749D0 (xx)
GR (1)	GR1002471B (xx)
HK (1)	HK142093A (xx)
HU (2)	HU199858B (xx)
IE (1)	IE59098B1 (xx)
IL (1)	IL85436A0 (xx)
IT (1)	IT1219447B (xx)
LU (1)	LU87129A1 (xx)
MY (1)	MY103206A (xx)
NL (1)	NL8800412A (xx)
NZ (1)	NZ223529A (xx)
PH (1)	PH25512A (xx)
PT (1)	PT86776B (xx)
SE (1)	SE467256B (xx)
ZA (1)	ZA881146B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU202111B (en) *	1988-03-11	1991-02-28	Sandoz Ag	Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5086072A (en) *	1990-06-18	1992-02-04	The United States Of America As Represented By The Department Of Health And Human Services	Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
EP0488959A3 (en) *	1990-11-28	1992-08-05	Sandoz Ltd.	New uses of competitive nmda receptor antagonists
US5260286A (en) *	1992-10-16	1993-11-09	Japan Tobacco, Inc.	2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
AU5693996A (en) *	1995-05-08	1996-11-29	Lonza A.G.	Biotechnical production process of piperazine r-alpha-carbox ylic acids and piperazine s-alpha-carboxylic acid amide
ES2206928T3 (es)	1997-05-12	2004-05-16	Ortho-Mcneil Pharmaceutical, Inc.	Piperacinas sustituidas con arilo utiles en el tratamiento de la hiperplasia benigna de prostata.
GB9821179D0 (en) *	1998-09-30	1998-11-25	Merck Sharp & Dohme	Therapeutic use
JP2008124531A (ja)	2006-11-08	2008-05-29	Nec Electronics Corp	半導体装置およびオーディオプロセッサチップ
EP3427729A1 (en)	2017-07-13	2019-01-16	Paris Sciences et Lettres - Quartier Latin	Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1248531A (en) *	1984-04-17	1989-01-10	Jeffrey C. Watkins	4-substituted piperazine-2-carboxylic acids

1987
- 1987-02-18 GB GB878703749A patent/GB8703749D0/en active Pending
1988
- 1988-02-11 LU LU87129A patent/LU87129A1/fr unknown
- 1988-02-12 FR FR888801782A patent/FR2610932B1/fr not_active Expired - Lifetime
- 1988-02-12 BE BE8800177A patent/BE1002427A3/fr active
- 1988-02-12 IT IT47631/88A patent/IT1219447B/it active
- 1988-02-15 MY MYPI88000155A patent/MY103206A/en unknown
- 1988-02-15 GB GB8803438A patent/GB2201676B/en not_active Expired - Lifetime
- 1988-02-16 NZ NZ223529A patent/NZ223529A/xx unknown
- 1988-02-16 DK DK079688A patent/DK168441B1/da not_active IP Right Cessation
- 1988-02-16 HU HU88746A patent/HU199858B/hu not_active IP Right Cessation
- 1988-02-16 PH PH36514A patent/PH25512A/en unknown
- 1988-02-16 CH CH549/88A patent/CH675125A5/de not_active IP Right Cessation
- 1988-02-16 CA CA000559170A patent/CA1327799C/en not_active Expired - Fee Related
- 1988-02-16 IE IE41388A patent/IE59098B1/en not_active IP Right Cessation
- 1988-02-16 AU AU11758/88A patent/AU613009B2/en not_active Ceased
- 1988-02-16 GR GR880100084A patent/GR1002471B/el not_active IP Right Cessation
- 1988-02-16 IL IL85436A patent/IL85436A0/xx not_active IP Right Cessation
- 1988-02-17 JP JP63036458A patent/JPH0723387B2/ja not_active Expired - Lifetime
- 1988-02-17 FI FI880744A patent/FI86733C/fi not_active IP Right Cessation
- 1988-02-17 DE DE3804936A patent/DE3804936C2/de not_active Expired - Fee Related
- 1988-02-17 KR KR1019880001680A patent/KR960015190B1/ko not_active IP Right Cessation
- 1988-02-17 SE SE8800541A patent/SE467256B/sv not_active IP Right Cessation
- 1988-02-17 PT PT86776A patent/PT86776B/pt not_active IP Right Cessation
- 1988-02-17 AT AT0036788A patent/AT391320B/de not_active IP Right Cessation
- 1988-02-18 ZA ZA881146A patent/ZA881146B/xx unknown
- 1988-02-18 NL NL8800412A patent/NL8800412A/nl not_active Application Discontinuation
- 1988-02-18 ES ES888800466A patent/ES2011319A6/es not_active Expired - Lifetime
1989
- 1989-10-16 ES ES8903482A patent/ES2021904A6/es not_active Expired - Lifetime
1993
- 1993-12-30 HK HK1420/93A patent/HK142093A/xx not_active IP Right Cessation
1995
- 1995-06-09 HU HU95P/P00176P patent/HU211269A9/hu unknown
- 1995-10-20 CY CY173995A patent/CY1739A/xx unknown

Also Published As

Publication number	Publication date
ES2021904A6 (es)	1991-11-16
IE59098B1 (en)	1994-01-12
HK142093A (en)	1994-01-07
KR960015190B1 (ko)	1996-11-01
PH25512A (en)	1991-07-24
MY103206A (en)	1993-05-29
IT8847631A0 (it)	1988-02-12
AU613009B2 (en)	1991-07-25
FI880744A0 (fi)	1988-02-17
ATA36788A (de)	1990-03-15
CA1327799C (en)	1994-03-15
NZ223529A (en)	1991-02-26
ZA881146B (en)	1989-10-25
ES2011319A6 (es)	1990-01-01
FR2610932A1 (fr)	1988-08-19
DE3804936C2 (de)	1997-02-13
HUT49361A (en)	1989-09-28
GB8803438D0 (en)	1988-03-16
IL85436A0 (en)	1988-07-31
DK79688D0 (da)	1988-02-16
DE3804936A1 (de)	1988-09-01
HU199858B (en)	1990-03-28
CH675125A5 (xx)	1990-08-31
DK79688A (da)	1988-08-19
IE880413L (en)	1988-08-18
PT86776B (pt)	1992-05-29
JPH0723387B2 (ja)	1995-03-15
GR880100084A (el)	1988-12-16
FI86733B (fi)	1992-06-30
GB2201676B (en)	1991-01-02
GB8703749D0 (en)	1987-03-25
KR880009944A (ko)	1988-10-06
IL85436A (xx)	1992-12-01
IT1219447B (it)	1990-05-18
BE1002427A3 (fr)	1991-02-05
DK168441B1 (da)	1994-03-28
LU87129A1 (fr)	1988-09-20
FI880744A (fi)	1988-08-19
AT391320B (de)	1990-09-25
GB2201676A (en)	1988-09-07
SE8800541D0 (sv)	1988-02-17
CY1739A (en)	1995-10-20
NL8800412A (nl)	1988-09-16
FR2610932B1 (fr)	1990-11-16
PT86776A (pt)	1988-03-01
HU211269A9 (en)	1995-11-28
FI86733C (fi)	1992-10-12
SE467256B (sv)	1992-06-22
AU1175888A (en)	1988-08-25
JPS63203691A (ja)	1988-08-23

Similar Documents

Publication	Publication Date	Title
GB2208476B (en)	1990-10-31	Improvements in or relating to apparatus for use in the treatment of spinal disorders
GB2207055B (en)	1990-12-19	Apparatus for use in the treatment of spinal disorders
KR100521829B1 (en)	2005-10-17	Compositions and Methods for the Treatment of Alzheimer's Disease, Central Nervous System Injury, and Inflammatory Diseases
EP0335901A4 (en)	1990-11-28	Methods and compositions for the treatment of non-ige-mediated diseases
SI0751129T1 (en)	1999-02-28	Substituted dihydrodibenzo(b,f)azepines, method for their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them
IL225192A (en)	2017-12-31	Combinations of dextromethorphan and quinidine for the preparation of mental illness, neuropathic pain or brain injury
HUP0100786A3 (en)	2002-12-28	Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
GB9014817D0 (en)	1990-08-22	Improvements in or relating to apparatus for use in the treatment of spinal disorders
MX9709238A (es)	1998-03-31	Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
MY103206A (en)	1993-05-29	Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it
AU642428B2 (en)	1993-10-21	Method of treatment of CNS disorders and /or pain using gamma aminobutyric acid autoreceptor antagonists
HU9202075D0 (en)	1992-10-28	Bcrf1 proteins of gamma-interferon inhibiting effect
EP0383171A3 (en)	1991-07-24	2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders
WO2002005801A3 (en)	2002-08-08	Compositions containing diacyltartaric salts of (e)-metanicotine
PH27352A (en)	1993-06-21	4-Benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
HK1047549A1 (en)	2003-02-28	Il6ril6 chimera for the treatment of neurodegeneraive diseases.
EP0273310A3 (en)	1991-01-09	5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
MY105555A (en)	1994-10-31	Heterocyclicguanidines as 5ht 3 antagonists.
PL310950A1 (en)	1996-01-08	Novel imidazole quinoxalinones, method of obtaining them and their application
AU608865B2 (en)	1991-04-18	Treatment of cerebral disorders
MY103584A (en)	1993-08-28	8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
ZA859695B (en)	1986-08-27	2-(arylalkyloxymethyl)morpholine,preparation thereof and their application as drugs which are useful in the treatment of disorders of the central nervous system
IL124730A0 (en)	1999-01-26	Compositions comprising bismuth and one or more antimicrobials for the prevention and treatment of gastrointestinal disorders
MX9804577A (es)	1998-10-31	Composiciones que contienen bismuto y uno o mas antimicrobianos, para la prevencion y tratamiento de trastornos gastrointestinales.
IL124729A (en)	2003-01-12	Use of bismuth for the manufacture of compositions for the treatment and prevention of gastrointestinal disorders

Legal Events

Date	Code	Title	Description
2003-09-04	ML	Lapse due to non-payment of fees